Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
US Stock MarketDetailed Quotes
TZUP Thumzup Media
- 4.120
- +0.080+1.98%
Close Apr 1 16:00 ET
- 4.120
- 0.0000.00%
Post 20:01 ET
38.84MMarket Cap-8.24P/E (TTM)
4.400High3.890Low125.81KVolume3.890Open4.040Pre Close522.45KTurnover4.53%Turnover RatioLossP/E (Static)9.43MShares7.89052wk High8.14P/B11.43MFloat Cap2.02052wk Low--Dividend TTM2.77MShs Float7.890Historical High--Div YieldTTM12.62%Amplitude2.020Historical Low4.152Avg Price1Lot Size
Thumzup Media Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 1,705.80%4.68M | 1,705.80%4.68M | -24.61%110.25K | 1.35%398.45K | -57.29%225.67K | -77.56%259.21K | -77.56%259.21K | -86.70%146.24K | -39.87%393.14K | 62.43%528.33K |
| -Cash and cash equivalents | 1,705.80%4.68M | 1,705.80%4.68M | -24.61%110.25K | 1.35%398.45K | -57.29%225.67K | -77.56%259.21K | -77.56%259.21K | -86.70%146.24K | -39.87%393.14K | 62.43%528.33K |
| Receivables | --17.04K | --17.04K | --0 | --25K | ---- | --0 | --0 | ---- | ---- | ---- |
| -Accounts receivable | --17.04K | --17.04K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| -Other receivables | ---- | ---- | ---- | --25K | ---- | ---- | ---- | ---- | ---- | ---- |
| Prepaid assets | 2,135.41%141.3K | 2,135.41%141.3K | 526.39%52.07K | 37.12%73.41K | 4,376.06%129.94K | 117.74%6.32K | 117.74%6.32K | -93.29%8.31K | --53.54K | --2.9K |
| Total current assets | 1,722.44%4.84M | 1,722.44%4.84M | 5.02%162.32K | 11.23%496.86K | -33.06%355.61K | -77.07%265.53K | -77.07%265.53K | -87.37%154.55K | -31.69%446.68K | 63.32%531.23K |
| Non current assets | ||||||||||
| Net PPE | 108.24%14.66K | 108.24%14.66K | -11.02%5.86K | -16.51%5.32K | 217.09%6.38K | 175.75%7.04K | 175.75%7.04K | 112.96%6.59K | 75.23%6.37K | -51.76%2.01K |
| -Gross PPE | ---- | ---- | -11.02%5.86K | -16.51%5.32K | --6.38K | ---- | ---- | --6.59K | --6.37K | ---- |
| Goodwill and other intangible assets | 74.34%248.63K | 74.34%248.63K | 169.62%253.3K | 248.00%230.84K | 270.75%186.93K | --142.61K | --142.61K | --93.95K | --66.33K | --50.42K |
| -Other intangible assets | 74.34%248.63K | 74.34%248.63K | 169.62%253.3K | 248.00%230.84K | 270.75%186.93K | --142.61K | --142.61K | --93.95K | --66.33K | --50.42K |
| Total non current assets | 75.93%263.29K | 75.93%263.29K | 157.78%259.16K | 224.84%236.16K | 268.69%193.32K | 5,761.89%149.65K | 5,761.89%149.65K | 3,150.44%100.54K | 1,901.10%72.7K | 1,156.51%52.43K |
| Total assets | 1,128.96%5.1M | 1,128.96%5.1M | 65.23%421.48K | 41.13%733.02K | -5.95%548.93K | -64.23%415.19K | -64.23%415.19K | -79.21%255.09K | -21.01%519.38K | 77.16%583.67K |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | 254.17%233.26K | 254.17%233.26K | ---- | ---- | --68.61K | -27.91%65.86K | -27.91%65.86K | --127.29K | --64.15K | ---- |
| -accounts payable | 254.17%233.26K | 254.17%233.26K | ---- | ---- | --68.61K | -27.91%65.86K | -27.91%65.86K | --127.29K | --64.15K | ---- |
| Current accrued expenses | --101.95K | --101.95K | ---- | ---- | --0 | ---- | ---- | --0 | --685.06K | ---- |
| Current debt and capital lease obligation | ---- | ---- | --140K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Current debt | ---- | ---- | --140K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Current liabilities | 408.96%335.2K | 408.96%335.2K | 83.45%233.52K | -84.81%113.82K | -1.32%68.61K | -82.40%65.86K | -82.40%65.86K | 294.62%127.29K | 194.07%749.21K | -72.24%69.53K |
| Non current liabilities | ||||||||||
| Total non current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Total liabilities | 408.96%335.2K | 408.96%335.2K | 83.45%233.52K | -84.81%113.82K | -1.32%68.61K | -82.40%65.86K | -82.40%65.86K | 294.62%127.29K | 194.07%749.21K | -72.24%69.53K |
| Shareholders'equity | ||||||||||
| Share capital | 22.71%9.57K | 22.71%9.57K | 3.49%7.92K | 6.56%7.91K | 8.48%7.87K | 7.81%7.8K | 7.81%7.8K | 5.96%7.65K | 17.46%7.42K | 18.51%7.25K |
| -common stock | 22.79%9.4K | 22.79%9.4K | 3.21%7.75K | 6.23%7.74K | 8.34%7.72K | 7.71%7.66K | 7.71%7.66K | 5.67%7.51K | 15.39%7.29K | 16.42%7.13K |
| -Preferred stock | 18.18%169 | 18.18%169 | 18.57%166 | 25.19%164 | 16.41%149 | 13.49%143 | 13.49%143 | 23.89%140 | --131 | --128 |
| Retained earnings | -70.27%-9.69M | -70.27%-9.69M | -32.37%-7.04M | -56.38%-6.57M | -114.52%-6.02M | -140.40%-5.69M | -140.40%-5.69M | -221.20%-5.32M | -208.51%-4.2M | -158.20%-2.81M |
| Paid-in capital | 139.49%14.45M | 139.49%14.45M | 32.75%7.22M | 81.15%7.18M | 95.97%6.49M | 89.73%6.03M | 89.73%6.03M | 91.28%5.44M | 125.49%3.97M | 185.68%3.31M |
| Total stockholders'equity | 1,264.70%4.77M | 1,264.70%4.77M | 47.08%187.96K | 369.42%619.2K | -6.58%480.32K | -55.59%349.33K | -55.59%349.33K | -89.30%127.8K | -157.07%-229.83K | 551.02%514.14K |
| Total equity | 1,264.70%4.77M | 1,264.70%4.77M | 47.08%187.96K | 369.42%619.2K | -6.58%480.32K | -55.59%349.33K | -55.59%349.33K | -89.30%127.8K | -157.07%-229.83K | 551.02%514.14K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
